Skip to main content

UBS Group AG

Position in ACET — Adicet Bio, Inc.

CIK 1610520 ZURICH, V8

Position in ACET

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$257,618
-$3,668 QoQ
Shares Held
29,817
-22.3% QoQ
Ownership
0.319%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 56 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACET Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,173,307 across 562 Biotechnology names. ACET ranks #327 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACET

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $257,618 29,817
2026-03-31 $261,286 38,368
2025-12-31 $31,970 3,797
2025-09-30 $17,364 21,438
2025-06-30 $11,289 18,508
2025-03-31 $48,349 64,039
2024-12-31 $195,505 203,229
2024-09-30 $59,909 41,604
2024-06-30 $194,609 160,835
2024-03-31 $125,814 53,538
2023-12-31 $42,672 22,578
2023-09-30 $5,940 4,337
2023-06-30 $65 27
2022-12-31 $1,051,245 117,589
2022-09-30 $245,565 17,269
2022-03-31 $10,923 547
2021-12-31 $172,888 9,885
2021-09-30 $1,191 152
2021-03-31 $22,144 1,693
2020-12-31 $8,064 574
2020-09-30 $16,646 1,400